|
Anti-Infective
Drugs Advisory Committee
Executive Secretary: Shalini Jain, PA-C, MBA,
(HFD-21), (301) 827-7001
October 14, 2004
June 9, 2004 Pediatric Subcommittee
February 3-4, 2004 Pediatric Subcommittee
February 2, 2004 Pediatric Subcommittee. Joint meeting
with the Psychopharmacologic Drugs Advisory Committee
[Top]
Arthritis
Drug Advisory Committee
Executive Secretary: Kimberly Littleton Topper,
MS (HFD-21), (301) 827-7001
June 2-3, 2004
- Notice
of Meeting (PDF)
- June 2, 2004 Final
Agenda (PDF)
(Word)
- June 2, 2004 Draft
Agenda (PDF)
(Word)
- June 2, 2004 Briefing
Information
- June
2, 2004 Errata Sheet (PDF)
(Word)
- June 2, 2004 Questions
(PDF) (Word)
- June 2, 2004 Slides
- June 2, 2004 Transcripts
(PDF) (Word)
- June 2, 2004 Concordance Index (PDF)
- June 3, 2004 Final
Agenda (PDF)
(Word)
- June 3, 2004 Questions
(PDF) (Word)
- June 3, 2004 Slides
- June 3, 2004 Transcripts
(PDF) (Word)
- June 2, 2004 Concordance Index (PDF)
[Top]
Cardiovascular
& Renal Drugs Advisory Committee
Executive Secretary: Cathy Groupe, RN, BSN, (HFD-21),
(301) 827-7001
September 10, 2004
[Top]
Dermatologic
and Ophthalmic Drugs Advisory Committee
Executive Secretary: Kimberly Littleton Topper,
MS (HFD-21), (301) 827-7001
August 27, 2004
July 12, 2004 Joint meeting with the Drug Safety and Risk
Management Advisory Committee
May 6-7, 2004 Joint meeting with the Nonprescription Drugs
Advisory Committee
February 26-27, 2004 Joint meeting with Drug Safety and
Risk Management Advisory Committee
- Notice
of Meeting (PDF)
- February 26-27, 2004 Agenda
(PDF) (Word)
- February
26-27, 2004 DS&RM Committee Roster (PDF)
(Word)
- February
26-27, 2004 Derm/Opth Committee Roster (PDF)
(Word)
- February 26-27,
2004 Consultants Roster (PDF)
(Word)
- February 26-27, 2004
Questions (PDF)
(Word)
- February 26-27, 2004 Briefing
Information
- February 26, 2004 Slides
- February 26, 2004 Transcript
(PDF) (Word)
- Concordance Index
(PDF)
- February 27, 2004 Slides
- February 27, 2004 Transcript
(PDF) (Word)
- Concordance Index
(PDF)
[Top]
Drug
Safety and Risk Management Advisory Committee
Executive Secretary: Shalini Jain, MBA (HFD-21),
(301) 827-7001
July 12, 2004 Joint meeting with the Dermatologic &
Ophthalmic Drugs Advisory Committee
May 5, 2004
February 26-27, 2004 Joint meeting with Dermatologic and
Ophthalmic Drugs Advisory Committee
- Notice
of Meeting (PDF)
- February 26-27, 2004 Agenda
(PDF) (Word)
- February
26-27, 2004 DS&RM Committee Roster (PDF)
(Word)
- February
26-27, 2004 Derm/Opth Committee Roster (PDF)
(Word)
- February 26-27,
2004 Consultants Roster (PDF)
(Word)
- February 26-27, 2004
Questions (PDF)
(Word)
- February 26-27, 2004 Briefing
Information
- February 26, 2004 Slides
- February 26, 2004 Transcript
(PDF) (Word)
- Concordance Index
(PDF)
- February 27, 2004 Slides
- February 27, 2004 Transcript
(PDF) (Word)
- Concordance Index
(PDF)
[Top]
Endocrinologic
& Metabolic Drugs Advisory Committee
Executive Secretary: Cathy Groupe, RN, BSN, (HFD-21),
(301) 827-7001
September 8, 2004
[Top]
Gastrointestinal
Drugs Advisory Committee
Executive Secretary: Thomas H. Perez, MPH, RPh
(HFD-21), (301) 827-7001
July 14, 2004
[Top]
Nonprescription
Drugs Advisory Committee
Executive Secretary: Hilda F. Scharen, MS, (HFD-21),
(301) 827-7001
May 6-7, 2004 Joint meeting with the Dermatologic and Ophtholmic
Drugs Advisory Committee
[Top]
Oncologic
Drugs Advisory Committee
Executive Secretary: Johanna M. Clifford, MS,
RN BSN (HFD-21), (301) 827-7001
December 1, 2004
July 27, 2004
May 3-4, 2004
- Notice
of Meeting (PDF)
- May 3-4, 2004 Final Agenda
(PDF) (Word)
- May 3-4, 2004 Draft Agenda
(PDF) (Word)
- May 3, 2004 Genasense
Questions (PDF)
(Word)
- May 3, 2004 RSR13
Questions (PDF)
(Word)
- May 3, 2004 Slides
- May 3, 2004 Briefing Information
- May 3, 2004 Transcript
(PDF) (Word)
- Concordance Index
(PDF)
- May 4, 2004 Briefing Information
- May 4, 2004 Slides
- May 4, 2004 Transcript
(PDF) (Word)
- Concordance Index
(PDF)
March 17, 2004 Pediatric Subcommittee
[Top]
Pharmaceutical
Science, Advisory Committee for
Executive Secretary: Hilda F. Scharen, MS (HFD),
(301) 827-7001
November 3-4, 2004 Clinical Pharmacology Subcommittee
October 19-20, 2004
July 20-21, 2004 Manufacturing Subcommittee
April 13-14, 2004
[Top]
Psychopharmacologic
Drugs Advisory Committee
Executive Secretary: Anuja M. Patel, MPH, (HFD-21),
(301) 827-7001
September 13-14, 2004 Joint meeting with the Pediatric
Advisory Committee
-
- Amendment of Notice (PDF)
- September
13-14, 2004 Final Agenda (PDF)
(Word)
- September 13-14, 2004
Draft Agenda (PDF)
(Word)
- September
13-14, 2004 Psychopharm Committee Roster (PDF)
(Word)
- September
13-14, 2004 Pediatric Committee Roster (PDF)
(Word)
- September
13-14, 2004 Guests/Consultants Roster (PDF)
(Word)
- September
13-14, 2004 Guests/Consultants Roster - Amendment (PDF)
(Word)
- September 13-14,
2004 Questions (PDF)
(Word)
- September 13-14, 2004
Briefing Information
- September 13-14, 2004
Addendum to FDA Briefing Information
- September 13-14,
2004 Summary Minutes (PDF)
(Word)
- September 13, 2004 Slides
- September 13, 2004
Transcript (PDF)
(Word)
- September 13,
2004 Concordance Index (PDF)
- September 14, 2004 Slides
- September
13, 2004 Errata Sheet (PDF)
(Word)
- September 13-14,
2004 Errata Sheet (PDF)
(Word)
- September 14, 2004
Transcript (PDF)
(Word)
- September 14,
2004 Concordance Index (PDF)
February 2, 2004 Joint meeting with the Anti-Infective
Drugs Advisory Committee.
[Top]
Pulmonary-Allergy
Drugs Advisory Committee
Executive Secretary: Teresa Watkins, RPh, (HFD-21),
(301) 827-7001
June 10, 2004
[Top]
Reproductive
Health Drugs, Advisory Committee for
Executive Secretary: Teresa Watkins, RPh, (HFD-21),
(301) 827-7001
December 2, 2004
Page updated:
April 5, 2005
|
|